215 related articles for article (PubMed ID: 6739312)
21. Amoxicillin-clavulanic acid in the treatment of lower respiratory tract infections caused by beta-lactamase-positive Haemophilus influenzae and Branhamella catarrhalis.
Wallace RJ; Steele LC; Brooks DL; Luman JI; Wilson RW; McLarty JW
Antimicrob Agents Chemother; 1985 Jun; 27(6):912-5. PubMed ID: 3875310
[TBL] [Abstract][Full Text] [Related]
22. [Bacteriological and clinical evaluation of BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
Haruta T; Kuroki S; Okura K; Kobayashi Y
Jpn J Antibiot; 1985 Feb; 38(2):359-72. PubMed ID: 3847523
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of BRL 25000 against Serratia marcescens, Enterobacter cloacae, and Citrobacter freundii in urinary tract infections.
Nakazawa H; Hashimoto T; Nishiura T; Mitsuhashi S
Antimicrob Agents Chemother; 1983 Sep; 24(3):437-9. PubMed ID: 6357078
[TBL] [Abstract][Full Text] [Related]
24. Amoxicillin/clavulanate in urinary tract infection.
Gasser TC; Larsen EH; Madsen PO
Urology; 1987 Jan; 29(1):111-4. PubMed ID: 3541346
[TBL] [Abstract][Full Text] [Related]
25. [A combination of amoxycillin with clavulanic acid (Augmentin) in various types of urinary tract infections caused by microbes producing beta-lactamase].
Prát V; Horcicková M; Hatala M; Liska M; Matousovic K
Cas Lek Cesk; 1985 Jun; 124(23):711-4. PubMed ID: 3874692
[No Abstract] [Full Text] [Related]
26. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in pediatric infections].
Hoshina H; Hirosawa H; Mikuni K; Ichihashi H
Jpn J Antibiot; 1985 Feb; 38(2):309-18. PubMed ID: 3847520
[TBL] [Abstract][Full Text] [Related]
27. Augmentin therapy in the treatment of urinary tract infections in general practice.
Abbas AM; Goel PK; Venkit N; Gowers E
Br J Clin Pract; 1984 Feb; 38(2):49-51. PubMed ID: 6704296
[No Abstract] [Full Text] [Related]
28. Amoxicillin-clavulanic acid (Augmentin).
Med Lett Drugs Ther; 1984 Nov; 26(674):99-100. PubMed ID: 6387417
[No Abstract] [Full Text] [Related]
29. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
Miyachi Y; Ueda S; Hayakawa F; Nakashima T; Hakamada S; Kuno K
Jpn J Antibiot; 1985 Feb; 38(2):423-30. PubMed ID: 4009951
[TBL] [Abstract][Full Text] [Related]
30. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
Sato Y; Iwata S; Akita H; Murai T; Ibara M; Oikawa T; Osano M
Jpn J Antibiot; 1985 Feb; 38(2):327-41. PubMed ID: 3847521
[TBL] [Abstract][Full Text] [Related]
31. Antibacterial activities of amoxicillin alone and in combination with clavulanic acid correlated with beta-lactamase production.
Hsu LY; Chang SC; Luh KT; Hsieh WC
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Aug; 24(3):272-80. PubMed ID: 1818798
[TBL] [Abstract][Full Text] [Related]
32. Augmentin (amoxycillin-clavulanic acid) compared with co-trimoxazole in urinary tract infections.
Fancourt GJ; Matts SG; Mitchell CJ
Br Med J (Clin Res Ed); 1984 Jul; 289(6437):82-3. PubMed ID: 6428687
[No Abstract] [Full Text] [Related]
33. Comparative in vitro activity of augmentin against community and hospital-acquired gram-negative bacteria.
Glupczynski Y; McGillavry G; Yourassowsky E
Acta Clin Belg; 1988; 43(2):109-14. PubMed ID: 3400375
[No Abstract] [Full Text] [Related]
34. In vitro efficacy of augmentin in beta-lactamase producing bacteria.
Agrawal SK; Goel MM; Misra AB
Indian J Med Res; 1987 Sep; 86():298-300. PubMed ID: 3501408
[No Abstract] [Full Text] [Related]
35. Amoxicillin-clavulanate (Clavulin). Infectious Diseases and Immunization Committee, Canadian Paediatric Society.
Infectious Diseases and Immunization Committee
CMAJ; 1985 Oct; 133(8):739. PubMed ID: 4042055
[No Abstract] [Full Text] [Related]
36. In-vitro activity of augmentin against clinically important gram-positive and gram-negative bacteria in comparison with other antibiotics.
Focht J; Klietmann W; Heilmann HD
Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Apr; 256(4):523-30. PubMed ID: 6564828
[TBL] [Abstract][Full Text] [Related]
37. [Progress in chemotherapeutic agents--beta-lactam antibiotics and beta-lactamase inhibitors].
Uzuka Y; Matsumoto K
Nihon Rinsho; 1986 Apr; 44(4):824-30. PubMed ID: 3531574
[No Abstract] [Full Text] [Related]
38. Clavulanate-potentiated amoxycillin: activity in vitro and bioavailability in the dog.
Bywater RJ; Palmer GH; Buswell JF; Stanton A
Vet Rec; 1985 Jan; 116(2):33-6. PubMed ID: 3871985
[TBL] [Abstract][Full Text] [Related]
39. Effect of low concentrations of clavulanic acid on the in-vitro activity of amoxycillin against beta-lactamase-producing Branhamella catarrhalis and Haemophilus influenzae.
Cooper CE; Slocombe B; White AR
J Antimicrob Chemother; 1990 Sep; 26(3):371-80. PubMed ID: 2121699
[TBL] [Abstract][Full Text] [Related]
40. Distribution of amoxicillin and clavulanic acid in infected animals and efficacy against experimental infections.
Boon RJ; Beale AS; Comber KR; Pierce CV; Sutherland R
Antimicrob Agents Chemother; 1982 Sep; 22(3):369-75. PubMed ID: 7137980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
